DK365279A - 3s, 5r)-penam-3-carboxylsyre-1,1-dioxider eller salte eller estere deraf og fremgangsmaade til fremstilling deraf - Google Patents

3s, 5r)-penam-3-carboxylsyre-1,1-dioxider eller salte eller estere deraf og fremgangsmaade til fremstilling deraf

Info

Publication number
DK365279A
DK365279A DK365279A DK365279A DK365279A DK 365279 A DK365279 A DK 365279A DK 365279 A DK365279 A DK 365279A DK 365279 A DK365279 A DK 365279A DK 365279 A DK365279 A DK 365279A
Authority
DK
Denmark
Prior art keywords
penam
dioxides
esters
salts
preparing
Prior art date
Application number
DK365279A
Other languages
English (en)
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK365279A publication Critical patent/DK365279A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK365279A 1978-09-01 1979-08-31 3s, 5r)-penam-3-carboxylsyre-1,1-dioxider eller salte eller estere deraf og fremgangsmaade til fremstilling deraf DK365279A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/938,848 US4241050A (en) 1978-09-01 1978-09-01 Penam 1,1-dioxides as beta-lactamase inhibitors

Publications (1)

Publication Number Publication Date
DK365279A true DK365279A (da) 1980-03-02

Family

ID=25472061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK365279A DK365279A (da) 1978-09-01 1979-08-31 3s, 5r)-penam-3-carboxylsyre-1,1-dioxider eller salte eller estere deraf og fremgangsmaade til fremstilling deraf

Country Status (7)

Country Link
US (1) US4241050A (da)
EP (1) EP0008917B1 (da)
JP (1) JPS6033397B2 (da)
CA (1) CA1134349A (da)
DE (1) DE2964101D1 (da)
DK (1) DK365279A (da)
IE (1) IE48631B1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI67553C (fi) * 1980-01-21 1985-04-10 Bristol Myers Co Foerfarande foer framstaellning av en terapeutiskt anvaendbar 2beta-klormetyl-2alfa-metylpenam-3alfa-karboxylsyrasulfon sater och estrar daerav
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
US5643722A (en) 1994-05-11 1997-07-01 Trustees Of Boston University Methods for the detection and isolation of proteins
US6210941B1 (en) 1997-06-27 2001-04-03 The Trustees Of Boston University Methods for the detection and isolation of proteins
US6358689B1 (en) * 1994-05-11 2002-03-19 Boston University Detection of markers in nascent proteins
AU5460500A (en) 1999-06-04 2000-12-28 Massachusetts Institute Of Technology Compositions and methods for the screening of compounds to enhance or reduce apoptosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
BE648188A (da) * 1963-05-29 1964-09-16
US3536698A (en) * 1968-02-27 1970-10-27 Lilly Co Eli Simplified method for esterification of antibiotics via carbonate anhydride intermediates
IN149747B (da) * 1977-06-07 1982-04-03 Pfizer

Also Published As

Publication number Publication date
JPS6033397B2 (ja) 1985-08-02
IE791661L (en) 1980-03-01
US4241050A (en) 1980-12-23
CA1134349A (en) 1982-10-26
DE2964101D1 (en) 1982-12-30
EP0008917A1 (en) 1980-03-19
IE48631B1 (en) 1985-04-03
JPS5535089A (en) 1980-03-11
EP0008917B1 (en) 1982-11-24

Similar Documents

Publication Publication Date Title
DK164545C (da) Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK6177A (da) Foretherede hydroxy-benzodiheterocycler eller salte deraf og fremgangsmade til fremstilling deraf
NO153459C (no) Toeymykningspreparat, samt fremgangsmaate for fremstilling derav.
NL7504870A (nl) Cryochirurgieinstrument.
NO145164C (no) Fremgangsmaate for fremstilling av polymerlateks.
NL7503476A (nl) Endoscopisch chirurgisch laserstelsel.
NL7803036A (nl) 4-(5-fluormethyl-2-pyridyloxy)fenoxyalkaan- carbonzuren en derivaten daarvan.
NL7503405A (nl) Chirurgisch laserstelsel.
DK282880A (da) Aminoalkylbenzen-derivater samt fremgangsmaade til fremstilling deraf
NO154587C (no) Anordning for dybdeindikeringsformaal eller liknende.
DK251478A (da) Fremgangsmaade til fremstilling af pencillansyre-1,1-dioxider
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK144568C (da) Fremgangsmaade til fremstilling af sterile enhedsportioner af dyrkningsmedier
DK291180A (da) Indolizinderivater samt fremgangsmaade til fremstilling deraf
NO790871L (no) Kjemoterapeutisk middel samt fremgangsmaate for fremstilling av dette
DK324078A (da) N-carloxyalkan-aminoalkan-polyhosphonsyrer og alkalimetalsalte deraf samt fremgangsmaade til fremstilling deraf
DK404980A (da) 2beta-acetoxymethyl-2alfa-methyl-(5r)-penam3alfa-carboxylsyre-1,1-dioxid eller estere eller salte deraf samt fremgangsmaade til fremstilling deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK500179A (da) 4,1-benzoxazepiner og thia-analoge samt fremgangsmaade til fremstilling deraf
AT362038B (de) Mittel zur stabilisierung von enzymen
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK162102C (da) Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf
NO150761C (no) 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd og fremgangsmaate for fremstilling derav
FI792206A7 (fi) Menetelmä uusien oksadiatsolopyrimidiini-johdannaisten valmistamiseksi.
DK159852C (da) Fremgangsmaade til fremstilling af penicillansyre-1,1-dioxid eller basesalte eller in vivo let hydrolyserbare estre deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment